Genitourinary Cancer News

Members of American Society for Radiation Oncology elected three new officers to ASTRO’s board of directors.

Mani Menon, MD, has been named chief of strategy and innovation in Mount Sinai Health System’s department of urology.

High urinary levels of cotinine appeared associated with a fourfold increased risk for recurrence of nonmuscle invasive bladder cancer in smokers, according to a study presented during the virtual European Association of Urology Congress.

The FDA today granted approval to enfortumab vedotin-ejfv for treatment of adults with locally advanced or metastatic urothelial cancer.

Pembrolizumab plus axitinib continued to exhibit superior efficacy to sunitinib as first-line therapy for advanced clear cell renal cell carcinoma, according to long-term follow-up of the randomized phase 3 KEYNOTE-426 trial.

Shilpa Gupta, MD, has been appointed director of genitourinary medical oncology at Taussig Cancer Institute and co-leader of the genitourinary oncology program at Cleveland Clinic.

A blood-based test demonstrated efficacy and high specificity in detecting multiple cancer types with diverse biological features, paving the way for a new screening option, according to research published in Annals of Oncology.

A high percentage of patients undergoing treatment for cancer achieved a sufficient antibody response to the BNT162b2 messenger RNA COVID-19 vaccine, according to study results published in JAMA Oncology.

Transurethral resection of bladder tumor plus systemic therapy induced clinical complete response among a large subset of patients with muscle-invasive bladder cancer, according to phase 2 study results.

Molecular profiling of solid tumors in children and young adults has a significant impact on diagnosis and treatment recommendations, according to results of an interim analysis presented during the virtual ASCO Annual Meeting.